Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiqiao Ai

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|April 27, 2023
DEEPCYPs: A deep learning platform for enhanced cytochrome P450 activity predictionDaiqiao Ai, Hanxuan Cai, Jiajia Wei, et al.
Journal of Medicinal Chemistry|December 12, 2022
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and SolutionsJindi Huang, Liye Chen, Jiangxia Wu, et al.
Frontiers in Pharmacology|October 28, 2022
A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitorsDaiqiao Ai, Jingxing Wu, Hanxuan Cai, et al.
European Journal of Medicinal Chemistry|September 11, 2021
Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinomaShiyang Zhai, Huimin Zhang, Rui Chen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|April 27, 2023
DEEPCYPs: A deep learning platform for enhanced cytochrome P450 activity predictionDaiqiao Ai, Hanxuan Cai, Jiajia Wei, et al.
Journal of Medicinal Chemistry|December 12, 2022
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and SolutionsJindi Huang, Liye Chen, Jiangxia Wu, et al.
Frontiers in Pharmacology|October 28, 2022
A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitorsDaiqiao Ai, Jingxing Wu, Hanxuan Cai, et al.
European Journal of Medicinal Chemistry|September 11, 2021
Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinomaShiyang Zhai, Huimin Zhang, Rui Chen, et al.
Pageof 1